agilon health, inc. (AGL) financials: revenue, earnings and cash flow
Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
agilon health, inc.’s revenue went from $794M in fiscal 2019 to $5.9B in fiscal 2025, growth of about 39.8% a year.
Net income in fiscal 2025 was -$391M, a net margin of -6.6%; the best year in this period was 2020 with -$60M.
Over the twelve months to September 30, 2026, revenue was $6.0B and net income -$87M.
Free cash flow was -$119M in fiscal 2025 and positive in 0 of the 7 years shown.
The diluted share count rose 40% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.9B | $6.1B | $4.3B | $2.4B | $1.5B | $1.2B | $794M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$154M | -$463M | -$292M | -$232M | -$105M | -$372M | -$57M | -$107M |
| Net income | -$87M | -$391M | -$260M | -$263M | -$107M | -$406M | -$60M | -$283M |
| EPS (diluted) | $-6.69 | $-24.50 | $-15.25 | $-12.00 | $-5.50 | $-25.75 | $-5.00 | $-23.97 |
| R&D | — | — | — | — | — | — | — | — |
| Revenue growth | — | −2.1% | +40.4% | +80.7% | +57.0% | +24.9% | +53.4% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4M | -$106M | -$58M | -$156M | -$131M | -$148M | -$53M | -$104M |
| Capital spending | -$13M | -$13M | -$13M | -$16M | -$15M | -$7M | -$2M | -$3M |
| Free cash flow | -$17M | -$119M | -$71M | -$172M | -$146M | -$155M | -$55M | -$107M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $0 | $0 | $200M | $0 | $0 | $7M | $0 |
| Stock-based pay | $58M | $49M | $51M | $69M | $28M | $292M | $7M | $5M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash | — | $174M | $188M | $108M | $877M | $1.0B | $107M | $139M |
| Debt | — | $37M | $44M | $52M | $56M | $60M | $77M | — |
| Equity | — | $127M | $471M | $662M | $1.0B | $1.1B | -$285M | -$232M |
| Total assets | — | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B | $446M | — |
| Shares (diluted) | 17M | 17M | 16M | 16M | 16M | 15M | 13M | 12M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -2.6% | -7.8% | -4.8% | -5.4% | -4.4% | -24.5% | -4.7% | -13.4% |
| Net margin | -1.5% | -6.6% | -4.3% | -6.1% | -4.5% | -26.7% | -4.9% | -35.6% |
| FCF margin | -0.3% | -2.0% | -1.2% | -4.0% | -6.1% | -10.2% | -4.5% | -13.4% |
| ROIC | — | -223.8% | -44.8% | -25.7% | -7.6% | -25.5% | — | — |
| ROE | — | -308.8% | -55.2% | -39.7% | -10.2% | -37.2% | 21.1% | 121.8% |
Frequently asked questions
What is agilon health, inc.’s annual revenue?
$5.9B in fiscal 2025 and $6.0B over the twelve months to September 30, 2026.
How much profit does agilon health, inc. make?
Net income was -$391M in fiscal 2025 (net margin -6.6%).
Is agilon health, inc.’s revenue growing?
No: revenue fell 2.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.